Stocks/CNTX

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

CNTX

↓ PDF (Pro)
Context Therapeutics Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$2.40
+4.13%today
MKT CAP
$218M
+0.0% · 1Y
Earnings History
-73.1%
-14.3%
-32.6%
+23.4%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$2.40
Low
$4.00
Analyst Mean
$6.00
High
$9.00
8 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-3.8x
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
ROE-56.2%
Debt / Equity0.54x
Free Cash Flow$-23,911,984
Insider Ownership1.2%
Institutional Ownership76.8%
Short % of Float1.08%
Days to Cover1.1d
1 Week+0.4%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
LEHR MARTIN AChief Executive OfficerBuy100,000$0.70$0.07M2025-06-09
MINAI-AZARY JENNIFER LYNNChief Financial OfficerBuy40,010$0.64$0.03M2025-06-06
LEVIT ALEX C.OfficerBuy20,000$0.58$0.01M2025-06-06
Top Holders
HolderType% HeldValueΔ SharesAs of
MPM Bioimpact LLCinstitution11.62%$0.03B-27.38%2025-12-31
Blue Owl Capital Holdings LPinstitution8.09%$0.02B+0.34%2025-12-31
Deep Track Capital, Lpinstitution8.08%$0.02B+0.00%2025-12-31
Nextech Invest, Ltd.institution8.08%$0.02B+0.00%2025-12-31
Avidity Partners Management, LPinstitution5.99%$0.01B-38.71%2025-12-31
Great Point Partners LLCinstitution5.10%$0.01B+0.00%2025-12-31
Franklin Resources, Inc.institution4.36%$0.01B+0.00%2025-12-31
Vanguard Group Incinstitution4.12%$0.01B+8.32%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund3.06%$0.01B+10.41%2025-12-31
Millennium Management Llcinstitution2.83%$0.01B+100.00%2025-12-31
Marshall Wace LLPinstitution2.82%$0.01B+7153.70%2025-12-31
Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUNDfund1.61%$0.00B+0.00%2026-01-31
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fundfund0.57%$0.00B+0.00%2025-12-31
Fidelity Concord Street Trust-Fidelity Extended Market Index Fundfund0.27%$0.00B+0.16%2026-02-28
Fidelity Concord Street Trust-Fidelity Total Market Index Fundfund0.11%$0.00B+0.00%2026-03-31
Fidelity Concord Street Trust-Fidelity Series Total Market Index Fundfund0.08%$0.00B+3.12%2026-03-31
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fundfund0.07%$0.00B+0.00%2026-02-28
VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd.fund0.06%$0.00B+0.00%2025-12-31
American Century ETF Trust-Avantis U.S. Small Cap Equity ETFfund0.06%$0.00B+92.97%2026-03-31
VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fundfund0.05%$0.00B-53.11%2025-12-31
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Recent Alerts
No alerts yet for CNTX.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.